Logo image of VCV

INVESCO CA VAL MUNI INC TR (VCV) Stock Price, Quote, News and Overview

NYSE:VCV - New York Stock Exchange, Inc. - US46132H1068 - Currency: USD

10.24  0 (0%)

Fundamental Rating

1

VCV gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. VCV may be in some trouble as it scores bad on both profitability and health. VCV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year VCV was profitable.
VCV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VCV reported negative net income in multiple years.
Each year in the past 5 years VCV had a positive operating cash flow.
VCV Yearly Net Income VS EBIT VS OCF VS FCFVCV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 0 50M -50M

1.2 Ratios

Industry RankSector Rank
ROA 2.11%
ROE 3.4%
ROIC 1.11%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VCV Yearly ROA, ROE, ROICVCV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 0 5 -5 10 -10

1.3 Margins

VCV's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of VCV has declined.
In the last couple of years the Gross Margin of VCV has declined.
Industry RankSector Rank
OM 38.71%
PM (TTM) 58.06%
GM 38.71%
OM growth 3Y-19.92%
OM growth 5Y-9.97%
PM growth 3YN/A
PM growth 5Y-20.89%
GM growth 3Y-19.88%
GM growth 5Y-9.98%
VCV Yearly Profit, Operating, Gross MarginsVCV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 0 -200 -400

2

2. Health

2.1 Basic Checks

Compared to 5 years ago, VCV has more shares outstanding
VCV Yearly Shares OutstandingVCV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 10M 20M 30M 40M
VCV Yearly Total Debt VS Total AssetsVCV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 200M 400M 600M 800M 1B

2.2 Solvency

VCV has an Altman-Z score of 0.94. This is a bad value and indicates that VCV is not financially healthy and even has some risk of bankruptcy.
VCV has a debt to FCF ratio of 6.87. This is a slightly negative value and a sign of low solvency as VCV would need 6.87 years to pay back of all of its debts.
VCV has a Debt/Equity ratio of 0.61. This is a neutral value indicating VCV is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 6.87
Altman-Z 0.94
ROIC/WACCN/A
WACCN/A
VCV Yearly LT Debt VS Equity VS FCFVCV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 200M 400M 600M

2.3 Liquidity

VCV has a Current Ratio of 2.77. This indicates that VCV is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 2.77 indicates that VCV has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.77
Quick Ratio 2.77
VCV Yearly Current Assets VS Current LiabilitesVCV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 5M 10M 15M 20M

0

3. Growth

3.1 Past

VCV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -25.75% yearly.
Measured over the past years, VCV shows a decrease in Revenue. The Revenue has been decreasing by -5.81% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5Y-25.75%
EPS Q2Q%-89.61%
Revenue 1Y (TTM)N/A
Revenue growth 3Y-6.32%
Revenue growth 5Y-5.81%
Sales Q2Q%20%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VCV Yearly Revenue VS EstimatesVCV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 10M 20M 30M 40M

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.68, the valuation of VCV can be described as expensive.
The average S&P500 Price/Earnings ratio is at 27.24. VCV is around the same levels.
Industry RankSector Rank
PE 27.68
Fwd PE N/A
VCV Price Earnings VS Forward Price EarningsVCV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 10.45
EV/EBITDA N/A
VCV Per share dataVCV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

VCV has a Yearly Dividend Yield of 6.94%, which is a nice return.
VCV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 6.94%

5.2 History

VCV has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of VCV decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
VCV Yearly Dividends per shareVCV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

VCV pays out 105.56% of its income as dividend. This is not a sustainable payout ratio.
DP105.56%
EPS Next 2YN/A
EPS Next 3YN/A
VCV Yearly Income VS Free CF VS DividendVCV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 0 50M -50M
VCV Dividend Payout.VCV Dividend Payout, showing the Payout Ratio.VCV Dividend Payout.PayoutRetained Earnings

INVESCO CA VAL MUNI INC TR

NYSE:VCV (8/4/2025, 8:04:00 PM)

10.24

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners13.38%
Inst Owner Change-4.42%
Ins OwnersN/A
Ins Owner Change0%
Market Cap491.01M
Analysts45
Price TargetN/A
Short Float %0.72%
Short Ratio3.51
Dividend
Industry RankSector Rank
Dividend Yield 6.94%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP105.56%
Div Incr Years1
Div Non Decr Years1
Ex-Date07-16 2025-07-16 (0.0646)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 27.68
Fwd PE N/A
P/S 15.84
P/FCF 10.45
P/OCF 10.45
P/B 0.93
P/tB 0.93
EV/EBITDA N/A
EPS(TTM)0.37
EY3.61%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.98
FCFY9.57%
OCF(TTM)0.98
OCFY9.57%
SpS0.65
BVpS11.03
TBVpS11.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.11%
ROE 3.4%
ROCE 1.41%
ROIC 1.11%
ROICexc 1.11%
ROICexgc 1.11%
OM 38.71%
PM (TTM) 58.06%
GM 38.71%
FCFM 151.61%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-21.05%
ROICexcg growth 5Y-12.11%
ROICexc growth 3Y-21.05%
ROICexc growth 5Y-12.1%
OM growth 3Y-19.92%
OM growth 5Y-9.97%
PM growth 3YN/A
PM growth 5Y-20.89%
GM growth 3Y-19.88%
GM growth 5Y-9.98%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 6.87
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.86
Cash Conversion N/A
Profit Quality 261.11%
Current Ratio 2.77
Quick Ratio 2.77
Altman-Z 0.94
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5Y-25.75%
EPS Q2Q%-89.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3Y-6.32%
Revenue growth 5Y-5.81%
Sales Q2Q%20%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3Y-24.98%
EBIT growth 5Y-15.2%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3Y135.91%
FCF growth 5Y2.01%
OCF growth 1YN/A
OCF growth 3Y135.91%
OCF growth 5Y2.01%